@article{44c1b2b460644d02bc20ec50ed6b79c7,
title = "Medical management of hepatorenal syndrome",
abstract = "Hepatorenal syndrome (HRS) is defined as the occurrence of renal dysfunction in a patient with end-stage liver cirrhosis in the absence of another identifiable cause of renal failure. The prognosis of HRS remains poor, with a median survival without liver transplantation of <6 months. However, understanding the pathogenesis of HRS has led to the introduction of treatments designed to increase renal perfusion and mean arterial blood pressure using vasopressors and albumin, which has led to improvement in renal function in ∼50\% of patients.",
keywords = "albumin, ascites, hepatorenal, vasopressors",
author = "Andrew Davenport and Jawad Ahmad and Ali Al-Khafaji and Kellum, \{John A.\} and Genyk, \{Yuri S.\} and Nadim, \{Mitra K.\}",
note = "Funding Information: Acknowledgements. The authors wish to acknowledge the University of Southern California for organization of ADQI 8th International Consensus Conference. This conference was supported by unrestricted educational grants from Ikaria, Gambro Renal Care, Otsuka Pharmaceutical, Nx-Stage Medical, IV League Inc. and Baxter Inc. ADQI is supported by a group of sponsors and no funding is accepted for the development of specific guidelines. None of the companies that provided financial support for this meeting were involved in any way in the organization of the meeting, the decision regarding invited faculty, the design and contents of the meeting, the collection, management, analysis and interpretation of the data and preparation, review or approval of the manuscript. ADQI 8th International Consensus Conference Participants: J.A., MD, Mount Sinai Hospital, USA; A.A.-K., MD, University of Pittsburgh School of Medicine, USA; Paolo Angeli, MD, University of Padova, Italy; Rinaldo Bellomo, MD, Melbourne University, Australia; Pat Brophy, MD, University of Iowa, USA; Jorge Cerda, MD, Albany Medical College, USA; Lakhmir S. Chawla, MD, George Washington Medical Center, USA; A.D., MD, University College London Medical School, UK; Connie Davis, MD, University of Washington, USA; Y.S.G., MD, University of Southern California, USA; Noel Gibney, MD, University of Alberta, Canada; J.A.K., MD, University of Pittsburgh School of Medicine, USA; M.K.N., MD, University of Southern California, USA; Neesh Pannu, MD, University of Alberta, Canada; Francesco Salerno, MD, University of Milan, Italy; Randall Sung, MD, University of Michigan, USA; Khajohn Tiranathanagul, MD, Chulalongkorn University, Thailand; Ashita Tolwani, MD, University of Alabama, USA and Florence Wong, MD, University of Toronto, Canada.",
year = "2012",
month = jan,
doi = "10.1093/ndt/gfr736",
language = "English",
volume = "27",
pages = "34--41",
journal = "Nephrology Dialysis Transplantation",
issn = "0931-0509",
publisher = "Oxford University Press",
number = "1",
}